Southern African Development Community countries are very connected. Highly mobile and migrant populations frequently cross borders, posing significant challenges to reaching a malaria-free region.
L’expertise universitaire, l’exigence journalistique
Articles sur Malaria
Affichage de 1 à 20 de 188 articles
Genetic diversity of a parasite population might help us watch for drug-resistant parasites.
This invasive mosquito thrives in the type of habitat commonly found in urban areas. This means that malaria could become more prevalent in African cities.
As ready as you are to be done with COVID-19, it's not going anywhere soon. A historian of disease describes how once a pathogen emerges, it's usually here to stay.
Malaria, tuberculosis and HIV/AIDS are regarded as the 'big three' infectious diseases. This is where scientists are at in their efforts to find a vaccine for each one.
A warming climate may change the types of viruses that thrive. A new report suggests that the threat of malaria may be replaced by dengue, for which there is no treatment and no cure.
We modelled surface water across Africa to show which parts of the continent are climatically-suitable for malaria – and how this will change.
With all the attention focussed on combating the spread of COVID-19 it's easy to forget the other health challenges that could affect us all.
Gene drive guarantees that a trait will be passed to the next generation. But should society use this tool to control insect populations?
Currently, there is no evidence that this highly effective antimalarial can treat COVID-19 – and the threat of drug resistance should deter us from using it indiscriminately.
Yellow fever, malaria and Ebola all spilled over from animals to humans at the edges of tropical forests. The new coronavirus is the latest zoonosis.
Mosquitoes that had Microsporidia MB - a tiny parasitic fungus - never became infected with malaria.
The pandemic coincides with the long rainy season in Kenya. Rain increases mosquito breeding sites, vector density and thus transmission of mosquito-borne diseases.
The US president has reignited controversy over the use of malaria drugs to guard against COVID-19. But there is little reliable evidence so far that this tactic is safe or effective.
On this continent, a child dies from malaria every two minutes. This is an unacceptable reality for a treatable and preventable disease.
If not addressed, there will be many more deaths from malaria and other diseases, indirectly linked to COVID-19 disruptions.
With recent calls for their use in combating COVID-19, there are concerns that chloroquine and hydroxychloroquine might become unavailable to people who need them.
Some of the false claims about coronavirus may be harmless. But others can be potentially dangerous.
To battle the coronavirus, strong regulatory protection from the FDA is essential.
Women must be included at decision making levels to advise on development, designing, delivery and implementation of tools that target health issues that affect them especially malaria.
Les contributeurs les plus fréquents
-
Chief Research Officer, Kenya Medical Research Institute
-
Professor of Molecular Parasitology and Medicine, St George's, University of London
-
Senior Lecturer in Public Health, Anglia Ruskin University
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
-
Board Certified Internal Medicine Physician and Public Health Scientist, MidMichigan Health, University of Michigan
-
Associate Professor, Deakin University
-
Associate Professor, School of Chemistry, University of Sydney
-
Cameron Webb est un·e adhérent·e de The Conversation
Clinical Associate Professor and Principal Hospital Scientist, University of Sydney
-
Associate Professor at the John Curtin School of Medical Research, Australian National University
-
Professor in Infectious Diseases, Queensland Institute of Medical Research
-
Epidemiologist, London School of Hygiene & Tropical Medicine
-
Associate Dean, College of Global Futures, Arizona State University
-
Co-head, Gilson/Crabb Laboratory & Senior Research Officer, Burnet Institute
-
Assistant Professor, Michigan State University
-
Associate Professor of Economics, University of East Anglia
